Continuing Education Credit Offered for 2026 Symposium Focusing on Intersection of Near-Death Experiences and Suicide ...

The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban ...

CoRegen's therapies are developed from the research by the late Dr. Bert O'Malley of Baylor College of Medicine. The ...

A study following more than 5,000 participants for 12 years found that straightforward clinical measurements can help identify sarcopenic obesity without relying on complex imaging methods such as MRI ...

The death of a nine-year-old boy weeks after he was operated on by surgeon who has since been suspended has been referred to a coroner.

Today at the Cardiovascular Research Technologies (CRT) annual conference taking place in Washington, DC, Dr. Christopher Chieh Yang Koo from National University Hospital Singapore, ...

In recent years, scientists have discovered that some chemotherapy drugs not only kill cancer cells directly, but at least in some patients, mysteriously also trigger their immune system to attack the ...

As previously presented, gedatolisib + palbociclib + fulvestrant ('gedatolisib triplet”) and gedatolisib + fulvestrant ('gedatolisib doublet”) reduced the risk of disease progression or death versus ...

Study finds up to 94% of papillary thyroid cancers in the past three decades were overdiagnosed, with stable mortality rates, despite soaring detection rates.

Sudden loss triggers distinct neurological consequences, with auditory memory playing a central role in how the brain ...

In adults aged 80 years or older, the use of statins is linked to a lower risk for all-cause mortality and new coronary events.

Myocardial ischemia, the primary driver of heart attacks, remains the leading cause of death and disability worldwide. Delays in diagnosis directly correlate with increased myocardial necrosis, higher ...